Skip to content

Research on the effect on concentrations of plasma GLP-1 in type2 diabetic patients by Spleen-Strengthening Decoction

Research on the effect on concentrations of plasma GLP-1 in type2 diabetic patients by Spleen-Strengthening Decoction

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IIC-16007833
Enrollment
Unknown
Registered
2016-01-26
Start date
2016-02-15
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes mellitus

Interventions

Chinese medicines section:Jianpi Qinghua Formula
Western Medicine:Sitagliptin
Stability of the treatment group:maintenance therapy

Sponsors

Shuguang Hospital affiliated with Shanghai University of TCM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 40 and 70 years old (including 40, 70); 2. type 2 diabetes patients who are standarded by Diabetes diagnosis standard; 3. Simple oral medications; 4. Relatively stable blood sugar control at least 3 months, glycosylated hemoglobin (HbA1c) is less than 9.0%; 5. Body mass index in 24 to 28; 6. Inform Consent Form.

Exclusion criteria

Exclusion criteria: 1. Who did not accord with the inclusive criteria; 2. Who are using the DPP 4 inhibitors or nearly used in a month; 3. Who are using traditional Chinese medicine (TCM) therapy or nearly used in a month; 4. Simple oral medications poor blood sugar control, the use of exogenous insulin injections; 5. Acute metabolic disorder, acute infection, serious heart kidney disease, merging other primary disease; 6. Pregnancy or breast-feeding women, pregnancy or lactation; 7. Other reasons are not suitable for clinical subjects, according to the researchers.

Design outcomes

Primary

MeasureTime frame
GLP-1 (totol active);GIP;insulin;Glucagon;glucose;

Countries

China

Contacts

Public ContactLu Hao
luhao403@163.com+86 13916719260

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026